登录

心脏病女性联盟WomenHeart和拜耳共同发起Understanding Her Heart倡议

WomenHeart and Bayer Join Forces to Enhance Heart Health Awareness and Education Among Women Across the U.S.

businesswire | 2024-05-10 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


WASHINGTON--(BUSINESS WIRE)--WomenHeart: The National Coalition for Women with Heart Disease, in collaboration with Bayer, is proud to announce the launch of the Understanding Her Heart: Women and Cardiovascular Disease initiative. This groundbreaking partnership aims to bolster awareness of heart disease risk factors among women, enhance accessibility to vital heart health information and resources, and mobilize women leaders to champion heart health education in their local communities and nationwide..

华盛顿——(商业新闻短讯)——女性心脏:全国心脏病女性联盟与拜耳合作,骄傲地宣布推出“了解她的心脏:女性与心血管疾病倡议”。这一开创性的伙伴关系旨在提高妇女对心脏病风险因素的认识,增强对重要心脏健康信息和资源的获取,并动员女性领导人在当地社区和全国范围内倡导心脏健康教育。。

Heart disease remains the leading cause of death for women in the United States, yet awareness of its prevalence and risk factors among women continues to lag. The Understanding Her Heart initiative seeks to bridge this gap by empowering women with the knowledge and tools they need, such as the Bayer Aspirin Heart Risk Assessment tool created in partnership with Huma Therapeutics Limited, to prioritize their heart health..

心脏病仍然是美国女性死亡的主要原因,但女性对其患病率和危险因素的认识仍然滞后。了解她的心脏倡议旨在通过赋予女性所需的知识和工具来弥合这一差距,例如与Huma Therapeutics Limited合作创建的拜耳阿司匹林心脏风险评估工具,以优先考虑她们的心脏健康。。

'At WomenHeart, we are committed to supporting and empowering women living with heart disease, as well as those at risk,' said Celina Gorre, CEO of WomenHeart. 'Through our partnership with Bayer and the Understanding Her Heart initiative, we aim to elevate awareness of cardiovascular disease risk factors among women and ensure that they have access to the resources and support necessary to lead heart-healthy lives.'.

WomenHeart首席执行官塞琳娜·戈尔(CelinaGorre)说,在WomenHeart,我们致力于支持和授权患有心脏病的女性以及有风险的女性通过与拜耳公司的合作关系和“了解她的心脏”倡议,我们旨在提高女性对心血管疾病危险因素的认识,并确保她们能够获得必要的资源和支持,从而过上健康的心脏生活。”。

The initiative will focus on several key objectives:

该倡议将侧重于几个关键目标:

Increasing Awareness: Understanding Her Heart will work to raise awareness of the risk of heart disease and its contributing factors among women across the country and encourage women to see their doctor to ensure they are getting screened and care.

提高认识:了解她的心脏将有助于提高全国女性对心脏病风险及其影响因素的认识,并鼓励女性去看医生,以确保她们得到筛查和护理。

Expanding Accessibility: The initiative will enhance accessibility to critical heart health information and educational resources, ensuring that women from different areas and backgrounds have access to the tools they need to prioritize their cardiovascular health.

扩大可及性:该倡议将增强对重要心脏健康信息和教育资源的可及性,确保来自不同地区和背景的妇女能够获得优先考虑心血管健康所需的工具。

Activating Women Leaders: Understanding Her Heart will activate and engage women leaders to serve as advocates for heart health education in their local communities, fostering a grassroots movement to improve overall heart health among women throughout the U.S.

激活女性领导者:了解她的心脏将激活和吸引女性领导者在当地社区担任心脏健康教育的倡导者,促进草根运动,以改善美国女性的整体心脏健康。

Targeting High-Risk Communities: The program will initially focus on communities with elevated risk factors for heart disease, including those impacted by climate and pollution. By addressing environmental factors that contribute to cardiovascular risk, Understanding Her Heart aims to make a meaningful impact on heart health outcomes in these communities..

针对高风险社区:该计划最初将重点关注心脏病风险因素升高的社区,包括受气候和污染影响的社区。通过解决导致心血管风险的环境因素,了解她的心脏旨在对这些社区的心脏健康结果产生有意义的影响。。

'Bayer is proud to partner with WomenHeart on the Understanding Her Heart initiative to further reinforce our mission of providing safe and effective self-care to all, especially women at greater risk of heart disease,' said Trevor Thrun, Vice President of Pain, Cardiology & Dermatology, North American Consumer Health at Bayer.

拜耳北美消费者健康部疼痛、心脏病和皮肤病副总裁特雷弗·特伦(TrevorThrun)说:“拜耳很荣幸与WomenHeart合作,开展“了解她的心脏”计划,进一步加强我们为所有人,尤其是心脏病风险较高的女性提供安全有效自我护理的使命。”。

'Together, we are committed to empowering women to learn about their personal risk factors regarding heart health and equipping them with the knowledge and resources to lead healthier lives.'.

“我们共同致力于赋予女性权力,让她们了解有关心脏健康的个人风险因素,并为她们提供知识和资源,让她们过上更健康的生活。”。

For more information about WomenHeart and its work to increase awareness of heart disease in women, please visit www.womenheart.org.

有关WomenHeart及其提高女性心脏病意识的工作的更多信息,请访问www.WomenHeart.org。

About WomenHeart:

关于WomenHeart:

WomenHeart: The National Coalition for Women with Heart Disease is the nation's leading voice for women living with or at risk of heart disease. WomenHeart is dedicated to promoting awareness, advocacy, and support for women with heart disease, empowering them to take charge of their heart health and improve outcomes..

女性心脏病:全国心脏病女性联盟是美国心脏病患者或有心脏病风险的女性的主要声音。WomenHeart致力于提高对心脏病女性的认识,倡导和支持,使她们能够管理自己的心脏健康并改善预后。。

About Bayer

关于拜耳

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population.

拜耳是一家全球性企业,在医疗保健和营养等生命科学领域拥有核心竞争力。根据其“人人健康,无人饥饿”的使命,该公司的产品和服务旨在通过支持应对全球人口不断增长和老龄化带来的重大挑战,帮助人们和地球繁荣发展。

Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros.

拜耳致力于推动可持续发展,并对其业务产生积极影响。与此同时,该集团旨在通过创新和增长来提高其盈利能力和创造价值。拜耳品牌代表着全世界的信任、可靠性和质量。2023财年,该集团雇佣了约10万人,销售额476亿欧元。

R&D expenses before special items amounted to 5.8 billion euros. For more information, go to bayer.com..

不含特殊项目的研发费用为58亿欧元。欲了解更多信息,请访问拜耳网。。

推荐阅读

拜耳公布在研疗法elinzanetant在两项关键性3期试验OASIS 1和OASIS 2的积极结果

药明康德 2024-05-18 08:07

拜耳两项后期研究新数据显示elinzanetant可缓解更年期症状

BioPharma Dive 2024-05-16 18:18

拜耳2024年Q1营收下降4.3%,裁减1500个岗位

药智网 2024-05-15 18:03

businesswire

6601篇

最近内容 查看更多

InfuSystem宣布2000万美元股票回购计划

5 小时后

NJOY向美国食品药品监督管理局提交NJOY ACE 2.0上市前烟草产品申请,采用蓝牙®接入限制技术

5 小时后

Procaps Group收到纳斯达克关于延迟提交20-F表格的通知

5 小时后

相关公司查看更多

Bayer

医药产品研发商

立即沟通

产业链接查看更多

所属赛道

运动医学